secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-02-10T23:59:59+00:00
Accession:  0001140361-25-003762
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics terminates $200M ATM equity facility with Cowen, effective Feb 14, 2025
--------------------------------------------------------------------------------

- Terminated Sales Agreement with Cowen and Company effective Feb 14, 2025.
- Agreement allowed sale of up to $200M in common stock via ATM program.
- Company provided notice on Feb 4, 2025; no reason disclosed for termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/0001140361-25-003762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036125003762/ef20043253_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-003762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer